trial · primary record
MRgART
Non-Small Cell Lung Cancer (Stage III)
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 60 |
| Primary completion | 2029-03 |
| Primary endpoint | Change in left ventricular ejection fraction (LVEF) |
| Registry ID | NCT07132918 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:43:39.863Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07132918
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.